Position in RIGL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,016,494
+$402,903 QoQ
Shares Held
25,984
+14.5% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 24%
Shared 0%
None 76%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,721,264 across 329 Biotechnology names. RIGL ranks #135 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in RIGL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,016,494 | 25,984 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $613,591 | 22,692 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $983,034 | 22,952 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $748,053 | 26,405 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $506,927 | 27,065 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $476,914 | 26,510 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $422,905 | 25,143 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $382,786 | 23,658 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $205,500 | 25,000 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $352,155 | 237,943 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $333,285 | 229,852 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $246,882 | 228,595 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $293,965 | 227,880 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $295,521 | 223,880 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $327,405 | 218,270 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $251,340 | 213,000 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $214,887 | 190,166 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $548,207 | 183,347 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $482,930 | 182,238 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $674,319 | 185,763 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $787,887 | 181,541 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $675,210 | 197,430 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $736,645 | 210,470 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $475,992 | 198,330 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $413,607 | 226,015 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $360,275 | 230,946 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||